Luis Palomera

Zaragoza, AR 50009, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL.

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL.

Journal: Cells
Published: July 16, 2025

Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Journal: Blood advances
Published: March 28, 2025

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Journal: Blood
Published: March 14, 2025

Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials.

Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials.

Journal: Clinical lymphoma, myeloma & leukemia
Published: October 22, 2024

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 01, 2024

Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Journal: Blood cancer discovery
Published: October 01, 2024

Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.

Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.

Journal: Annals of hematology
Published: July 24, 2024

Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 22, 2024

Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry.

Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry.

Journal: HemaSphere
Published: April 26, 2024

Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.

Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.

Journal: Haematologica
Published: April 23, 2024

Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma.

Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma.

Journal: Blood
Published: April 16, 2024

High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience.

High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience.

Journal: HemaSphere
Published: March 07, 2024
Showing 1-12 of 88

Last Updated: 09/26/2026